340 related articles for article (PubMed ID: 19628262)
1. Does histologic subtype affect oncologic outcomes after nephron-sparing surgery?
Crépel M; Isbarn H; Capitanio U; Liberman D; Jeldres C; Sun M; Shariat SF; Widmer H; Arjane P; Graefen M; Montorsi F; Patard JJ; Perrotte P; Karakiewicz PI
Urology; 2009 Oct; 74(4):842-5. PubMed ID: 19628262
[TBL] [Abstract][Full Text] [Related]
2. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
Leibovich BC; Blute M; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2004 Mar; 171(3):1066-70. PubMed ID: 14767272
[TBL] [Abstract][Full Text] [Related]
3. Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment.
Crépel M; Jeldres C; Perrotte P; Capitanio U; Isbarn H; Shariat SF; Liberman D; Sun M; Lughezzani G; Arjane P; Widmer H; Graefen M; Montorsi F; Patard JJ; Karakiewicz PI
Urology; 2010 Feb; 75(2):271-5. PubMed ID: 19962740
[TBL] [Abstract][Full Text] [Related]
4. Cytoreductive nephron-sparing surgery does not appear to undermine disease-specific survival in patients with metastatic renal cell carcinoma.
Hutterer GC; Patard JJ; Colombel M; Belldegrun AS; Pfister C; Guille F; Artibani W; Montorsi F; Pantuck AJ; Karakiewicz PI
Cancer; 2007 Dec; 110(11):2428-33. PubMed ID: 17941033
[TBL] [Abstract][Full Text] [Related]
5. A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study.
Capitanio U; Cloutier V; Zini L; Isbarn H; Jeldres C; Shariat SF; Perrotte P; Antebi E; Patard JJ; Montorsi F; Karakiewicz PI
BJU Int; 2009 Jun; 103(11):1496-500. PubMed ID: 19076149
[TBL] [Abstract][Full Text] [Related]
6. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.
Becker F; Siemer S; Humke U; Hack M; Ziegler M; Stöckle M
Eur Urol; 2006 Feb; 49(2):308-13. PubMed ID: 16359779
[TBL] [Abstract][Full Text] [Related]
7. A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Marechal JM; Klotz L; Skinner E; Keane T; Claessens I; Sylvester R; ; ; ;
Eur Urol; 2007 Jun; 51(6):1606-15. PubMed ID: 17140723
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML
Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of multiple ipsilateral renal tumours found at the time of planned nephron-sparing surgery.
Krambeck A; Iwaszko M; Leibovich B; Cheville J; Frank I; Blute M
BJU Int; 2008 Jun; 101(11):1375-9. PubMed ID: 18454793
[TBL] [Abstract][Full Text] [Related]
10. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes.
Pahernik S; Cudovic D; Roos F; Melchior SW; Thüroff JW
BJU Int; 2007 Jul; 100(1):26-9. PubMed ID: 17552949
[TBL] [Abstract][Full Text] [Related]
11. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M
BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
[TBL] [Abstract][Full Text] [Related]
12. Nephron-sparing surgery versus radical nephrectomy in the treatment of intracapsular renal cell carcinoma up to 7cm.
Antonelli A; Cozzoli A; Nicolai M; Zani D; Zanotelli T; Perucchini L; Cunico SC; Simeone C
Eur Urol; 2008 Apr; 53(4):803-9. PubMed ID: 18036730
[TBL] [Abstract][Full Text] [Related]
13. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma.
Margulis V; Tamboli P; Jacobsohn KM; Swanson DA; Wood CG
BJU Int; 2007 Dec; 100(6):1235-9. PubMed ID: 17979923
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm.
Peycelon M; Hupertan V; Comperat E; Renard-Penna R; Vaessen C; Conort P; Bitker MO; Chartier-Kastler E; Richard F; Rouprêt M
J Urol; 2009 Jan; 181(1):35-41. PubMed ID: 19012929
[TBL] [Abstract][Full Text] [Related]
15. Excellent long-term cancer control with elective nephron-sparing surgery for selected renal cell carcinomas measuring more than 4 cm.
Becker F; Siemer S; Hack M; Humke U; Ziegler M; Stöckle M
Eur Urol; 2006 Jun; 49(6):1058-63; discussion 1063-4. PubMed ID: 16630686
[TBL] [Abstract][Full Text] [Related]
16. Outcome of nephron-sparing surgery for T1b renal cell carcinoma.
Joniau S; Vander Eeckt K; Srirangam SJ; Van Poppel H
BJU Int; 2009 May; 103(10):1344-8. PubMed ID: 19040528
[TBL] [Abstract][Full Text] [Related]
17. Quality of life and perioperative outcomes after retroperitoneoscopic radical nephrectomy (RN), open RN and nephron-sparing surgery in patients with renal cell carcinoma.
Gratzke C; Seitz M; Bayrle F; Schlenker B; Bastian PJ; Haseke N; Bader M; Tilki D; Roosen A; Karl A; Reich O; Khoder WY; Wyler S; Stief CG; Staehler M; Bachmann A
BJU Int; 2009 Aug; 104(4):470-5. PubMed ID: 19239445
[TBL] [Abstract][Full Text] [Related]
18. Single institutional experience with nephron-sparing surgery for pathologic stage T3bNxM0 renal cell carcinoma confined to the renal vein.
Woldu SL; Barlow LJ; Patel T; Hruby GW; Benson MC; McKiernan JM
Urology; 2010 Sep; 76(3):639-42. PubMed ID: 20163841
[TBL] [Abstract][Full Text] [Related]
19. The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma.
Krambeck AE; Leibovich BC; Lohse CM; Kwon ED; Zincke H; Blute ML
J Urol; 2006 Nov; 176(5):1990-5; discussion 1995. PubMed ID: 17070231
[TBL] [Abstract][Full Text] [Related]
20. Elective nephron sparing surgery for renal cell carcinoma larger than 4 cm.
Pahernik S; Roos F; Röhrig B; Wiesner C; Thüroff JW
J Urol; 2008 Jan; 179(1):71-4; discussion 74. PubMed ID: 17997423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]